Subscribe To
Sanofi's (sny) hemophilia a candidate meets study endpoints
Sanofi (SNY) and Sobi's factor VIII replacement therapy candidate, efanesoctocog alfa, achieves clinica...
March 10, 2022, 12:02 pm
Moderna begins phase 2 trial for bivalent covid-19 booster for 'fall booster season'
Shares of Moderna Inc. MRNA, +10.22% were down 1.9% in premarket trading on Thursday after the company said it began dosing patients in a Phase 2 clin...
March 10, 2022, 9:10 am
Genmab (gmab), abbvie lymphoma candidate gets orphan drug tag
Genmab (GMAB) and AbbVie are co-developing epcoritamab as a potential treatment for non-Hodgkin's lymphoma, follicular lymphoma. The FDA grants orphan...
March 9, 2022, 10:32 am
Omega therapeutics to present preclinical data for otx-2002 at the american association for cancer research annual meeting 2022
CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a development-stage biotechnology company pioneeri...
March 8, 2022, 5:05 pm
Bluebird (blue) posts q4 loss, hit by regulatory pipeline woes
bluebird (BLUE) reports in-line fourth-quarter 2021 earnings but misses on revenues. The FDA placing clinical holds on BLUE's pipeline ...
March 7, 2022, 6:46 pm
5 short squeeze candidates to watch: kaival tops the list again, oil and agriculture stocks join with rising prices
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...
March 7, 2022, 9:26 am
5 short squeeze candidates to watch: kaival tops the list again, oil and agriculture stocks join with rising prices
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...
March 7, 2022, 9:26 am
5 short squeeze candidates to watch: kaival tops the list again, oil and agriculture stocks join with rising prices
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...
March 7, 2022, 9:26 am
Starboard value has options to build value at webchat provider liveperson
Starboard Value recently sent a letter to webchat provider LivePerson, nominating four candidates for t...
March 5, 2022, 8:46 am
Starboard value has options to build value at webchat provider liveperson
Starboard Value recently sent a letter to webchat provider LivePerson, nominating four candidates for t...
March 5, 2022, 8:46 am
Skye bioscience partners with novatech heath holdings for phase i trial of glaucoma drug candidate
Skye Bioscience inc (OTCQB:SKYE) announced that it has entered into an agreement with Novotech Health Holdings, a leading full-service contract resear...
March 3, 2022, 9:34 am
Skye bioscience partners with novatech heath holdings for phase i trial of glaucoma drug candidate
Skye Bioscience inc (OTCQB:SKYE) announced that it has entered into an agreement with Novotech Health Holdings, a leading full-service contract resear...
March 3, 2022, 9:34 am
Skye bioscience partners with novatech heath holdings for phase i trial of glaucoma drug candidate
Skye Bioscience inc (OTCQB:SKYE) announced that it has entered into an agreement with Novotech Health Holdings, a leading full-service contract resear...
March 3, 2022, 9:34 am
Axsome (axsm) posts narrower-than-expected q4 loss
Axsome Therapeutics (AXSM) reports a narrower-than-expected Q4 loss. The company is actively preparing to support the commercial launch of its two und...
March 2, 2022, 1:47 pm
Axsome (axsm) posts narrower-than-expected q4 loss
Axsome Therapeutics (AXSM) reports a narrower-than-expected Q4 loss. The company is actively preparing to support the commercial launch of its two und...
March 2, 2022, 1:47 pm
Axsome (axsm) posts narrower-than-expected q4 loss
Axsome Therapeutics (AXSM) reports a narrower-than-expected Q4 loss. The company is actively preparing to support the commercial launch of its two und...
March 2, 2022, 1:47 pm
Fda grants breakthrough therapy status to pfizer's rsv vaccine candidate
Shares of Pfizer Inc. PFE, -2.54% gained 0.6% in premarket trading on Wednesday after the company said its experimental respiratory syncytial virus (R...
March 2, 2022, 8:06 am
Fda grants breakthrough therapy status to pfizer's rsv vaccine candidate
Shares of Pfizer Inc. PFE, -2.54% gained 0.6% in premarket trading on Wednesday after the company said its experimental respiratory syncytial virus (R...
March 2, 2022, 8:06 am
Fda grants breakthrough therapy status to pfizer's rsv vaccine candidate
Shares of Pfizer Inc. PFE, -2.54% gained 0.6% in premarket trading on Wednesday after the company said its experimental respiratory syncytial virus (R...
March 2, 2022, 8:06 am
Sale of walgreen's boots in flux in uk with less bidders, market upset
The multibillion-pound sale of U.K. drugstore Boots has been derailed after a possible buyer walked away and several bidders raised concerns about fin...
March 1, 2022, 11:50 pm